Neuberger Berman Group LLC Jazz Pharmaceuticals PLC Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 7,217 shares of JAZZ stock, worth $789,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,217

Previous 7,350 1.81%

Holding current value

$789,467

Previous $885,000 12.99%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $13,824 - $15,824	-133 Reduced 1.81%	7,217 $770,000
Q1 2024 May 13, 2024	BUY	$115.19 - $132.77 $846,646 - $975,859	7,350 New	7,350 $885,000
Q4 2023 Feb 09, 2024	SELL	$114.26 - $136.0 $31,535 - $37,536	-276 Reduced 3.93%	6,749 $830,000
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $153,598 - $182,945	1,259 Added 21.83%	7,025 $909,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $180,810 - $217,208	1,476 Added 34.41%	5,766 $714,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $63,774 - $76,383	476 Added 12.48%	4,290 $627,000
Q4 2022 Feb 13, 2023	SELL	$129.72 - $159.85 $11,415 - $14,066	-88 Reduced 2.26%	3,814 $607,000
Q3 2022 Nov 15, 2022	SELL	$126.59 - $161.18 $76,713 - $97,675	-606 Reduced 13.44%	3,902 $520,000
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $95,998 - $114,351	-678 Reduced 13.07%	4,508 $704,000
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $227,518 - $282,028	1,755 Added 51.15%	5,186 $782,000
Q4 2021 Feb 11, 2022	BUY	$119.87 - $145.67 $169,616 - $206,123	1,415 Added 70.19%	3,431 $416,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $2,058 - $2,956	16 Added 0.8%	2,016 $243,000
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $11,694 - $13,608	73 Added 3.79%	2,000 $330,000
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $13,366 - $15,441	-89 Reduced 4.41%	1,927 $293,000
Q4 2020 Feb 10, 2021	BUY	$140.71 - $165.05 $10,131 - $11,883	72 Added 3.7%	2,016 $322,000
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $6.79 Million - $9.28 Million	-64,414 Reduced 97.07%	1,944 $277,000
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $1.91 Million - $2.44 Million	20,004 Added 43.15%	66,358 $7.32 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $439,050 - $764,310	-5,004 Reduced 9.74%	46,354 $4.62 Million
Q4 2019 Feb 12, 2020	BUY	$117.65 - $153.73 $6.04 Million - $7.9 Million	51,358 New	51,358 $7.67 Million
Q1 2019 May 13, 2019	SELL	$121.81 - $142.95 $342,773 - $402,261	-2,814 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$115.94 - $166.74 $12.4 Million - $17.8 Million	-106,988 Reduced 97.44%	2,814 $349,000
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $23,024 - $25,821	-143 Reduced 0.13%	109,802 $18.5 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $1.08 Million - $1.36 Million	-7,400 Reduced 6.31%	109,945 $18.9 Million
Q3 2017 Nov 15, 2017	BUY	$142.62 - $155.6 $16.7 Million - $18.3 Million	117,345	117,345 $17.2 Million

Others Institutions Holding JAZZ

# of Institutions

490

Shares Held

57M

Call Options Held

155K

Put Options Held

152K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.86B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Jazz Pharmaceuticals PLC Transaction History